Literature DB >> 19943806

Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness.

Karin Nilsson1, Lars Gustafson, Michael Nornholm, Björn Hultberg.   

Abstract

BACKGROUND: Total plasma homocysteine (tHcy) concentration is increased in elderly patients with mental illness. Also, patients with vascular disease have significantly higher plasma tHcy concentration compared with patients without vascular disease. Apolipoprotein E (apoE) status is associated with cardiovascular disease and a major genetic risk factor is inheritance of the e4 allele. In the present study, we investigated the association between plasma tHcy and apoE status.
METHODS: The relation between apoE status, plasma tHcy and vascular disease was investigated in a cohort of consecutively enrolled elderly patients with mental illness (n=328).
RESULTS: Plasma tHcy concentrations were increased (p<0.01) in carriers of APOE4 (13.6 micromol/L; 9.2-21.7 micromol/L) compared to non-carriers (12.4 micromol/L; 8.3-19.9 micromol/L). The proportion of patients with vascular disease was significantly (p<0.001) increased among carriers (61%) compared to non-carriers (42%). An increased percentage (p<0.001) of APOE4 carriers was observed in patients with Alzheimer's disease (AD) with (71%) or without vascular disease (42%), and in patients with vascular dementia (VaD) (54%) compared to a reference group (34%).
CONCLUSIONS: Since carriers of APOE4 showed an increased likelihood of vascular disease, these patients need more intensive control of other modifiable vascular risk factors. Furthermore, the association between plasma tHcy and the presence of APOE4 might be attributed to an increased proportion of vascular disease in APOE4 carriers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19943806     DOI: 10.1515/CCLM.2010.013

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  5 in total

Review 1.  Atrial Fibrillation - A Common Ground for Neurology and Cardiology.

Authors:  Fawzi Abukhalil; Aakash Bodhit; Peter Y Cai; Saeed Ansari; Spandana Thenkabail; Sarah Ganji; Pradeepan Saravanapavan; Chandana Chandra Shekhar; Michael F Waters; Thomas M Beaver; Vishnumurthy Shushrutha Hedna
Journal:  J Atr Fibrillation       Date:  2013-08-31

2.  Apolipoprotein E ε4/4 genotype limits response to dietary induction of hyperhomocysteinemia and resulting inflammatory signaling.

Authors:  Charles E Seaks; Erica M Weekman; Tiffany L Sudduth; Kevin Xie; Brandi Wasek; David W Fardo; Lance A Johnson; Teodoro Bottiglieri; Donna M Wilcock
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-13       Impact factor: 6.960

3.  Ocimum Sanctum Linn: A Potential Adjunct Therapy for Hyperhomocysteinemia-Induced Vascular Dementia.

Authors:  Jagadeesh Prasad Pasangulapati; Arun Reddy Ravula; Dinesh Reddy Kanala; Shanmukhi Boyina; Kiran Gangarapu; Hemanth Kumar Boyina
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Precision Nutrition for Alzheimer's Prevention in ApoE4 Carriers.

Authors:  Nicholas G Norwitz; Nabeel Saif; Ingrid Estrada Ariza; Richard S Isaacson
Journal:  Nutrients       Date:  2021-04-19       Impact factor: 5.717

5.  Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia.

Authors:  Jack C de la Torre
Journal:  Cardiovasc Psychiatry Neurol       Date:  2012-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.